913
Views
56
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Mefloquine Blockade of Pannexin1 Currents: Resolution of a Conflict

, &
Pages 131-137 | Received 03 Nov 2009, Accepted 21 Jan 2010, Published online: 11 Mar 2010

REFERENCES

  • Bao L, Locovei S, Dahl G (2004). Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 572: 65–68.
  • Barbe MT, Monyer H, Bruzzone R (2006). Cell-cell communication beyond connexins: the pannexin channels. Physiology (Bethesda). 21: 103–114.
  • Bargiotas P, Monyer H, Schwaninger M (2009). Hemichannels in cerebral ischemia. Curr Mol Med. 9: 186–194.
  • Brocks DR, Mehvar R (2003). Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiralantimalarial drugs. Clin Pharmacokinet. 42: 1359–1382.
  • Bruzzone R, Barbe MT, Jakob NJ, Monyer H (2005). Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem. 92: 1033–1043.
  • Contreras JE, Sánchez HA, Véliz LP, Bukauskas FF, Bennett MV, Sáez JC (2004). Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev. 47: 290–303.
  • Cruikshank SJ, Hopperstad M, Younger M, Connors BW, Spray DC, Srinivas M (2004). Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci U S A. 101: 12364–12369.
  • Del Corsso C, Srinivas M, Urban-Maldonado M, Moreno AP, Fort AG, Fishman GI, Spray DC (2006). Transfection of mammalian cells with connexins and measurement of voltagesensitivity of their gap junctions. Nat Protoc. 4: 1799–809.
  • Iglesias R, Dahl G, Qiu F, Spray DC, Scemes E (2009). Pannexin 1: The molecular substrate of astrocyte “hemichannels.” J Neurosci. 29: 7092–7097.
  • Iglesias R, Locovei S, Roque A, Alberto AP, Dahl G, Spray DC, Scemes E (2008). P2X7 receptor-Pannexin1 complex: Pharmacology and signaling. Am J Physiol Cell Physiol. 295: C752–C760.
  • Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Núñez G (2007). Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity. 26: 433–443.
  • Kimelberg HK (2005). Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy [review]. Glia. 50: 389–397.
  • Locovei S, Wang J, Dahl G (2006). Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett. 580: 239–244.
  • Ma W, Hui H, Pelegrin P, Surprenant A (2009). Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther. 328: 409–418.
  • Nilius B, Droogmans G. (2003). Amazing chloride channels: An overview. Acta Physiol. Scand. 177: 119–147.
  • Panchin YV (2005). Evolution of gap junction proteins—The pannexin alternative. J Exp Biol. 208(Pt 8): 1415–1419.
  • Pelegrin P, Barroso-Gutierrez C, Surprenant A (2008). P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol. 180: 7147–7157.
  • Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, Carlsson SK, Scemes E, Keane RW, Dahl G (2009). The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem. 284: 18143–18151.
  • Skals M, Jorgensen NR, Leipziger J, Praetorius HÁ (2009). Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc Natl Acad Sci U S A. 106: 4030–4035.
  • Spray DC, Ye ZC, Ransom BR (2006). Functional connexin “hemichannels”: A critical appraisal. Glia. 54: 758–773.
  • Suadicani SO, Brosnan CF, Scemes E (2006). P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J Neurosci. 26: 1378–1385.
  • Thompson RJ, Zhou N, MacVicar BA (2006). Ischemia opens neuronal gap junction hemichannels. Science. 312: 924–927.
  • White TW, Deans MR, O’Brien J, Al-Ubaidi MR, Goodenough DA, Ripps H, Bruzzone R (1999). Functional characteristics of skate connexin35, a member of the gamma subfamily of connexins expressed in the vertebrate retina. Eur J Neurosci. 11: 1883–1890.
  • Weiss SM, Benwell K, Cliffe A, Gillespie RJ, Knight AR, Lerpiniere J, Misra A, Pratt RM, Revell D, Upton R, Dourish CT (2003). Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease. Neurology. 61: S101–S106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.